title: An update on surgical and medical management strategies for intracerebral hemorrhage.
abstract: Intracerebral hemorrhage (ICH) accounts for ∼ 10 to 15% of all strokes and is one of the major causes of stroke-related death and disability. After the initial hemorrhage, further bleeding and edema contribute to secondary damage and worsened outcomes. As such, goals of previous and ongoing trials are to prevent continued bleeding, as well as mitigate the impact of cerebral edema. Although no trials have shown a definite functional outcome benefit with a given intervention, much progress has been made recently. This review focuses on recent developments that inform the acute management of ICH.
authors: University of Cincinnati Neuroscience Institute, Cincinnati, Ohio.
authors: Natalie
authors: N
authors: Kreitzer
authors: University of Cincinnati Neuroscience Institute, Cincinnati, Ohio.
authors: Opeolu
authors: O
authors: Adeoye
mesh_terms: D000925:Anticoagulants / Q000008:administration & dosage; D002543:Cerebral Hemorrhage / Q000175:diagnosis / Q000188:drug therapy* / Q000601:surgery*; D017326:Clinical Trials, Phase III as Topic / Q000379:methods; D019468:Disease Management; D006488:Hemostasis, Surgical / Q000379:methods; D006801:Humans; D012307:Risk Factors
chemical_list: D000925:Anticoagulants